A study comparing two medicines Ropivacaine and Bupivacaine for pain relief after breast surgery using an ultrasound guided block

A comparative study of 0.5 percentage Ropivacaine vs 0.25 percentage Bupivacaine for postoperative analgesia using ultrasound guided serratus anterior plane block for breast surgeries A prospective double blinded randomized controlled study - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093598

Enrollment

120

Registered

2025-08-25

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: serratus anterior plane block: 20ml 0.5 percent ropivacaine for group A and 0.25 percent bupivacaine for group B Control Intervention1: serratus anterior plane block: 20ml 0.5 percent r

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 and 2 Patient scheduled for elective breast surgeries.

Exclusion criteria

Exclusion criteria: Patient who has local infection at local site. Patient who are allergic to local anaesthestics. Patient who are unable to comprehend the study protocol.

Design outcomes

Primary

Measure	Time frame
To compare the duration and quality of postoperative pain relief between 0.5 percentage Ropivacaine and 0.25 percentage Bupivacaine using an ultrasound guided serratus anterior plane block in breast surgery patients, measured by pain scores Visual analogue scale and time to first rescue analgesic.Timepoint: 6 hour,12 hour,24 hour	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDrSathish Arjunan

Shri Sathya Sai Medical College And Research Institute

drjagangovindasamy@gmail.com9940623333

Outcome results